Toward a new era of reef solutions. The scope and scale of threats facing coral reefs demand new ways of approaching the questions that need to be answered in order […]
Benchmark’s new sea lice medicine receives Norwegian approval. Benchmark’s Ecotsan®Vet has received Marketing Authorisation (MA) from the Norwegian Medicines Agency. A statement from Benchmark said: “The granting of the MA is […]